Our results suggest that STD is a promising compound that may be useful in future novel anti-leukemia strategies by targeting multiple pathways along with ceramide generation through the activation of Fas and CerS6, leading to p38 kinase activation in lipid rafts. Here, FAS is linked to leukemia.